FIELD: medicine, pharmaceutics.
SUBSTANCE: claimed invention relates to compound of formula I: where: R1 represents R6C(O)-, R6SO2-, (R6)2NC(O)-; R2 represents hydrogen, -CF3 or R8; R3 represents -T-R9; R4 represents -COOH or -COOR8; R5 represents -CH2F or -CH2O-2, 3, 5, 6 - tetrafluorophenyl; R6 represents R6a or R6b; two R6 groups, together with the atom to which they are bound optionally form 3-10-member aromatic or non-aromatic ring; and where each R6 is independently substituted with 6 substituents, independently selected from R; R6a and R6b each independently represents (C1-C3)-aliphatic group, (C6-C10)-aryl-, (C6-C10)-aryl-(C1-C12) aliphatic group; R represents halogen, -OR7, -R7; each R7 is independently selected from: hydrogen, (C1-C12)-aliphatic group, (C6-C10)-aryl; R8 represents (C1-C12)-aliphatic group; T represents direct bond or (C1-C6)-aliphatic group, where to 2 aliphatic carbon atoms in T can be optionally substituted with O; R9 is optionally substituted (C6-C10)-aryl or (C5-C10) - heteroaryl, invention also relates to pharmaceutical composition, to methods of treatment, inhibition of caspase-mediated processes, to method of cell preservation with application of formula I compounds application of such compositions for treatment of caspase-mediated diseases and to methods of obtaining formula I compounds.
EFFECT: obtained and described are novel compounds, which can be useful in treatment of caspase-mediated diseases.
38 cl, 22 ex
Title | Year | Author | Number |
---|---|---|---|
CASPASE INHIBITORS AND USE THEREOF | 2004 |
|
RU2372335C2 |
SUBSTITUTED DERIVATIVES OF PURINE, METHODS FOR THEIR PREPARING AND PHARMACEUTICAL PREPARATION | 1997 |
|
RU2228335C2 |
NEW CYCLOALKYL DERIVATIVES AS INHIBITORS OF BONE RESORPTION AND ANTAGONISTS OF VITRONECTINE RECEPTOR | 1997 |
|
RU2180331C2 |
INHIBITORS OF SERINE PROTEASES, IN PARTICULAR, HC-3-HC4A PROTEASE | 2004 |
|
RU2412198C2 |
SUBSTITUTED 2-OXO- AND 2- THIOXO- DIHYDROQUINOLINE-3-CARBOXAMIDES AS KCNQ2/3 MODULATORS | 2011 |
|
RU2581362C2 |
SUBSTITUTED ISOQUINOLINE AND ISOQUINOLINONE DERIVATIVES AS Rho-KINASE INHIBITORS | 2007 |
|
RU2455302C2 |
METHODS AND INTERMEDIATE PRODUCTS | 2005 |
|
RU2433127C2 |
CASPASE INHIBITOR PRODRUGS | 2006 |
|
RU2427582C2 |
PPAR-SUPPORTING COMPOUNDS FOR TREATING METABOLIC DISEASES | 2014 |
|
RU2687490C2 |
ISOXAZOLINES AND ISOXAZOLES, METHOD OF INHIBITION OF PLATELET AGGREGATION, PHARMACEUTICAL COMPOSITION INHIBITING PLATELET AGGREGATION | 1994 |
|
RU2149871C1 |
Authors
Dates
2011-02-27—Published
2005-11-21—Filed